- Home
- EPC vs SDGR Comparison
EPC vs SDGR Comparison
Compare EPC & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPC
- SDGR
- Stock Information
- Founded
- EPC 1999
- SDGR 1990
- Country
- EPC United States
- SDGR United States
- Employees
- EPC N/A
- SDGR N/A
- Industry
- EPC Package Goods/Cosmetics
- SDGR Biotechnology: Pharmaceutical Preparations
- Sector
- EPC Consumer Discretionary
- SDGR Health Care
- Exchange
- EPC Nasdaq
- SDGR Nasdaq
- Market Cap
- EPC 1.4B
- SDGR 1.5B
- IPO Year
- EPC 2000
- SDGR 2020
- Fundamental
- Price
- EPC $24.44
- SDGR $20.61
- Analyst Decision
- EPC Buy
- SDGR Buy
- Analyst Count
- EPC 7
- SDGR 5
- Target Price
- EPC $33.00
- SDGR $32.80
- AVG Volume (30 Days)
- EPC 756.0K
- SDGR 1.3M
- Earning Date
- EPC 08-05-2025
- SDGR 07-30-2025
- Dividend Yield
- EPC 2.56%
- SDGR N/A
- EPS Growth
- EPC N/A
- SDGR N/A
- EPS
- EPC 1.72
- SDGR N/A
- Revenue
- EPC $2,224,500,000.00
- SDGR $230,492,000.00
- Revenue This Year
- EPC $0.90
- SDGR $24.44
- Revenue Next Year
- EPC $2.33
- SDGR $22.17
- P/E Ratio
- EPC $13.60
- SDGR N/A
- Revenue Growth
- EPC N/A
- SDGR 22.29
- 52 Week Low
- EPC $22.61
- SDGR $16.60
- 52 Week High
- EPC $41.50
- SDGR $28.47
- Technical
- Relative Strength Index (RSI)
- EPC 37.52
- SDGR 40.98
- Support Level
- EPC $23.05
- SDGR $20.04
- Resistance Level
- EPC $24.43
- SDGR $20.88
- Average True Range (ATR)
- EPC 0.76
- SDGR 1.23
- MACD
- EPC 0.08
- SDGR -0.16
- Stochastic Oscillator
- EPC 28.53
- SDGR 11.03
About EPC Edgewell Personal Care Company
Edgewell Personal Care Co is a personal-care company. The operating segments of the company include Wet Shave, Sun and Skin Care and Feminine Care. Some of the brands offered by the company include Edge, Skintimate, Personna, Schick, Carefree, Playtex, Banana Boat and Hawaiian Tropic. It derives a majority of its revenue from the United States.
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.